Rockefeller Capital Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History
Bought
Maintained
Sold
Other funds holding QNTM
Rockefeller Capital Management's QNTM Position: Q3 2026 in Review
Rockefeller Capital Management sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2026, closing a stake of 30 shares — an estimated $109 sold.
Rockefeller Capital Management first reported a position in QNTM in Q4 2021 and held it in 9 quarters. The position peaked at $4K in Q4 2021. 22 funds tracked by Wall St. Rank hold QNTM as of Q3 2026.
- Rockefeller Capital Management reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2026 after selling out during the quarter.
- Rockefeller Capital Management sold 30 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2026, an estimated $109.
- Rockefeller Capital Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2021 and held it in 9 quarters.
- Rockefeller Capital Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $4K in Q4 2021.
- 22 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.